New hormone for lowering blood sugar
2012-04-04
(Press-News.org) New evidence points to a hormone that leaves muscles gobbling up sugar as if they can't get enough. That factor, which can be coaxed out of fat stem cells, could lead to a new treatment to lower blood sugar and improve metabolism, according to a report in the April issue of Cell Metabolism, a Cell Press publication.
This new fat-derived hormone would appear to be a useful alternative or add-on to insulin; it can do essentially the same job, sending glucose out of the bloodstream and into muscle.
"It's like you've opened the door and now the glucose can come in," said Jonathan Graff of the University of Texas Southwestern Medical Center.
Graff's team manipulated a key developmental pathway in the fat stem cells of mice to find that the animals showed remarkably low blood sugar levels. The animals' muscles were taking up glucose at two to four times the usual rate thanks to an abundance of glucose transporters at their surfaces. That discovery was all the more striking because the animals also lacked fat stores, a condition known as lipodystrophy that normally results in just the opposite: high blood sugar and diabetes.
The mice could respond normally to insulin, but insulin surprisingly had nothing to do with the muscles' unusual appetite for sugar. The source for the change wasn't anything inherently different in the muscle itself either; it was something about those manipulated fat stem cells.
Further experiments revealed that the mouse muscles continued to take up extra sugar when they were isolated in the lab and exposed to blood serum. "It showed these effects were likely secondary to blood-borne signals sent by the manipulated fat cell progenitors," Graff says.
That signal can be generated only by fat stem cells, not mature fat cells. When the researchers made the same developmental manipulation in adult fat cells, they saw no such effect on blood sugar or muscle.
The findings highlight a new fat to muscle hormonal cue that would seem to have real therapeutic promise.
"If we can purify this factor and give it to people, there is potential for its use to lower and help control blood sugar," Graff says. Alternatively, there might be a way to encourage fat stem cells in the body to produce more of the anti-diabetic factor themselves.
###
Zeve et al.: "Wnt signaling activation in adipose progenitors promotes insulin-independent muscle glucose uptake."
END
ELSE PRESS RELEASES FROM THIS DATE:
2012-04-04
Philadelphia, PA, April 3, 2012 – A new report published online today in the Journal of the Academy of Nutrition and Dietetics systematically reviews and updates the evidence underlying the recommendation in the Dietary Guidelines for Americans 2010 to consume a diet low in energy density (ED). The report addresses the growing body of evidence linking ED, or the number of calories in a given amount of food, and body weight in adults as well as children and adolescents. The systematic review concluded that there is strong and consistent evidence in adults showing that consuming ...
2012-04-04
The drug known as rapamycin is widely used by cancer and transplant patients, and there are hints that it might even help us put off old age and live longer. But, it also comes with a downside: rapamycin leads to diabetes in as many as 15 percent of the people who take it.
Now, researchers reporting in the April Cell Metabolism, a Cell Press publication, have figured out why that is. The drug turns the insulin signal off in muscle, to prevent muscle cells from taking blood sugar in.
"This is a drug that is pretty well known for its benefits," said Pere Puigserver ...
2012-04-04
CHICAGO, IL – Researchers and doctors at the North Shore-LIJ Health System and the Feinstein Institute for Medical Research have discovered that blood can help determine the best treatment plan for patients with ovarian cancer. More specifically, a genetic marker embedded in deoxyribonucleic acid (DNA), called microRNA, indicates if a patient with ovarian cancer has a benign or cancerous tumor, and that she will benefit from chemotherapy after surgery on the tumor. This data will be presented at the American Association for Cancer Research (AACR) Annual Meeting to be held ...
2012-04-04
MONTREAL, April 3, 2012 – Researchers at the University of Montreal's Sainte-Justine Hospital have identified how neural cells like those in our bodies are able to build up resistance to opioid pain drugs within hours. Humans have known about the usefulness of opioids, which are often harvested from poppy plants, for centuries, but we have very little insight into how they lose their effectiveness in the hours, days and weeks following the first dose. "Our study revealed cellular and molecular mechanisms within our bodies that enables us to develop resistance to this medication, ...
2012-04-04
Scientists at the University of Southampton have discovered a new process that controls the ability of arteries to regulate blood pressure.
Arteries are able to control blood pressure by relaxing and constricting. In healthy people, the ability of arteries to relax or constrict is kept in balance. However, this balance shifts in people who are at risk of developing high blood pressure or atherosclerosis. There is more constriction within the arteries so blood cannot flow freely increasing the risk of heart attacks and stroke.
Researchers in Southampton, led by Dr ...
2012-04-04
April in Israel is a month with many special events including: festivals, concerts, performances, street fairs and walking tours which are tremendously varied so that there is something for every one of all ages and tastes. April's warm temperatures mean that more outdoor events can take place, and combined with the Passover holiday for which kids are away from school, it means that April is a great time to be in Israel. Additionally, as the local holiday coincides with the Easter holiday, many Christian tourists choose to visit Israel in April, as the majority of them ...
2012-04-04
Research: The risk of cancer in the first seven years after metal-on-metal hip replacement compared with other bearings and the general population: a linkage study between the National Joint Registry of England and Wales and Hospital Episode Statistics
Patients who have had metal-on-metal hip replacements are no more likely to develop cancer in the first seven years after surgery than the general population, although a longer-term study is required, a study published on bmj.com today claims.
A recent BMJ and BBC Newsnight investigation looked into the potentially high ...
2012-04-04
Neonatal services in England have seen a considerable improvement since the introduction of new guidelines in 2003, a study published on bmj.com claims.
The new guidelines were set out to help increase the proportion of premature babies born in a specialist care unit and reduce the amount of acute (within 24 hours of birth) postnatal transfers from one hospital to another. The specialised delivery and management of premature babies is associated with improved outcomes while acute postnatal transfer is associated with adverse outcomes.
Researchers from the Imperial ...
2012-04-04
CHICAGO— Hepatitis B-infected patients with significantly longer telomeres—the caps on the end of chromosomes that protect our genetic data— were found to have an increased risk of getting liver cancer compared to those with shorter ones, according to findings presented by researchers at Jefferson's Kimmel Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2012.
The relative telomere length in hepatitis B-infected cases with liver cancer was about 50 percent longer than the telomere length of the cancer-free hepatitis B-infected controls.
A ...
2012-04-04
ROCHESTER, Minn. -- The dietary supplement gamma-linoleic acid can inhibit the growth of a
subset of pancreatic cancer cells and selectively promote cancer cell death in mice, a Mayo Clinic study has found. The supplement, a fatty acid also known as GLA, worked particularly well when combined with the chemotherapy drug gemcitabine, the researchers say. The findings were presented today by Mayo Clinic pathologist Ruth Lupu, Ph.D., at the American Association for Cancer Research (AACR) Annual Meeting 2012. "One of the most devastating facts about pancreatic cancer is the ...
LAST 30 PRESS RELEASES:
[Press-News.org] New hormone for lowering blood sugar